{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-12-18&hansardHeading=Drugs", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2018-12-18&hansardHeading=Drugs", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-12-18&_metadata=all&hansardHeading=Drugs", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-12-18&_page=0&hansardHeading=Drugs", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-12-18&hansardHeading=Drugs", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-12-18&hansardHeading=Drugs", "items" : [{"_about" : "http://data.parliament.uk/resources/1027714", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1027714/answer", "answerText" : {"_value" : "<p>The independently chaired Clinical Priorities Advisory Group met in November 2018 to make prioritisation recommendations for investments in specialised service for the 2019/20 financial year. Final investment decisions will be announced shortly. A second prioritisation round for investment in 2019/20 will be held next year.<\/p><p> <\/p><p>The baseline budget for prioritisation in 2019/20 has been set at £25.7 million reflecting a 2.7% increase on the 2018/19 budget. The availability of any additional funding to support prioritisation will be kept under review between now and May/June 2019 when the second round of investment decisions will be taken for the 2019/20 financial year.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-12-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-12-20T15:58:15.86Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-12-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer on 11 September to Question number 169109 on Social Care: Drugs, (a) when the 2019-20 planning process was completed and (b) what the level of funding is for the 2019-20 prioritisation process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1383", "label" : {"_value" : "Biography information for Mark Tami"}
      }
      , "tablingMemberConstituency" : {"_value" : "Alyn and Deeside"}
      , "tablingMemberPrinted" : [{"_value" : "Mark Tami"}
      ], "uin" : "203288"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}